11
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Successful Management of Retroperitoneal Malignant Fibrous Histiocytoma Involving Both Kidneys

, , , &
Pages 208-210 | Published online: 09 Jul 2009

REFERENCES

  • O'Brien JS, Stout AP. Malignant fibrous xanthomas. Cancer 1964; 17: 1445–55.
  • Weis SW, Enzinger FM. Malignant fibrous histiocytoma. An analysis of 200 cases. Cancer 1978; 41: 2250–66.
  • Kearny MM, Soule EH, Ivins JC. Malignant fibrous histiocytoma. A retrospective study of 167 cases. Cancer 1980; 45: 167–78.
  • Enjoji M, Hashimoto H, Tsuneyoshi M, et al. Malignant fibrous histiocytoma. A clinicopathologic study of 130 cases. Acta Pathol Jpn 1980; 30: 727–41.
  • Usher SM, Beckley S, Merrin CE. Malignant fibrous histiocytoma of the retroperitoneum and genitourinary tract: a clinicopathological correlation and review of the literature. J Urol 1979; 122: 105–9.
  • Vera Donoso CD, Llopis B, Froufe A, et al. Retro-peritoneal malignant fibrous histiocytoma. Eur Urol 1988; 15: 302–5.
  • Goldman SM, Hartman DS, Weiss SW. The varies radiographic manifestations of retroperitoneal malignant fibrous histiocytoma revealed through 27 cases. J Urol 1986; 135: 33–8.
  • Poon MC, Durant JR, Norgard MJ, et al. Inflammatory fibrous histiocytoma: an important variant of malignant fibrous histiocytoma highly responsive to chemotherapy. Ann Intern Med 1982; 97: 858–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.